Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Copanlisib Plus Venetoclax in R/R DLBCL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04572763
Recruitment Status : Not yet recruiting
First Posted : October 1, 2020
Last Update Posted : October 1, 2020
Sponsor:
Collaborators:
AbbVie
Bayer
Information provided by (Responsible Party):
Jennifer Crombie, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : July 1, 2023
Estimated Study Completion Date : July 1, 2025